SNP Genotyping and Analysis Market Overview:
As per MRFR analysis, the SNP Genotyping and Analysis Market Size was estimated at 24.30 (USD Billion) in 2023.
The SNP Genotyping and Analysis Market is expected to grow from 28.66 (USD Billion) in 2024 to 115.92 (USD Billion) by 2032. The SNP Genotyping and Analysis Market CAGR (growth rate) is expected to be around 19.09% during the forecast period (2024 - 2032).
Key SNP Genotyping and Analysis Market Trends Highlighted
The global SNP Genotyping and Analysis market is experiencing significant advancements, fueled by technological innovations and rising demand for personalized medicine.
Key market drivers include the growing prevalence of chronic diseases, increased awareness of genetic testing, and advancements in next-generation sequencing (NGS) technologies.
Opportunities for growth lie in the development of new applications such as non-invasive prenatal testing, precision medicine, and the study of complex genetic disorders.
Recent trends in the market include the integration of artificial intelligence (AI) and machine learning (ML) to enhance data analysis and interpretation.
The convergence of genomics and other omics data is also driving the demand for comprehensive and integrative analysis solutions.
Furthermore, the emergence of portable and point-of-care genotyping devices is expanding the accessibility and convenience of genetic testing.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
SNP Genotyping and Analysis Market Drivers
Advances in Sequencing Technology
The rise of next-generation sequencing technologies has positively influenced the progress of the Global SNP Genotyping and Analysis Market.
These devices are superior to traditional Sanger sequencing due to their high speed, correctness, and ability to sequence relatively large genomes at lower costs.
These advantages allow researchers to sequence more DNA samples; thus, scientists have created a large body of knowledge regarding the structure of the human genome and discovered a great number of new genetic variations.
As the technology keeps advancing, mainly due to the developments in the field of the third-generation sequencing and single-cell analysis that are supposed to be even more powerful and adaptable, the growth of the Global SNP Genotyping and Analysis Market is going to be further supported.
Growing Prevalence of Chronic Diseases
There is another strong factor, which helps to drive the growing tendency within the Global SNP Genotyping and Analysis Market, and it is the rising prevalence of chronic diseases, such as tumor, cardiovascular diseases and diabetes.
These diseases may be characterized by genetic factors, and SNP Genotyping and Analysis may be used to define their development in a particular individual.
Today, genetic aspects of chronic diseases are studied thoroughly, and the development of appropriate, personalized treatment and preventive measures may be applied in the field of medicine.
The interest in personalized means of treatment will continue to increase, which will contribute to the growing tendency.
Government Initiatives and Funding
The Global SNP Genotyping and Analysis Market is primarily encouraged to evolve and grow due to government initiatives and funding across the globe.
Governments available globally invest in various research projects and initiatives that are aimed at providing information on the genetic nature of diseases and coming up with new diagnostic and therapeutic solutions.
Such funding assists research institutions, universities, and biotech firms to take part in the same and achieve significant steps.
Government agencies are growing in understanding of the genetic processes that are underway and are, therefore, supporting the Global SNP Genotyping and Analysis Market.
SNP Genotyping and Analysis Market Segment Insights:
SNP Genotyping and Analysis Market Sample Type Insights
The Sample Type segment of the Global SNP Genotyping and Analysis Market is projected to exhibit the fastest growth in the forthcoming years because of the rising adoption of non-invasive liquid biopsy techniques and the increasing demand for personalized medicines.
In the context of the different sample types, the segment of genomic DNA is anticipated to remain the largest one in terms of revenue, reaching an amount of $356.2 million by 2023.
The key driving factor behind the expansion of this segment is the wide availability of the corresponding samples and their common use in the field of genetic testing.
At the same time, RNA-based genotyping is occurring in increasing popularity, especially in the industry of cancer research. RNA sequencing allows the gaining of the corresponding data on the levels of gene expression which can be utilized for the purposes of identifying the biomarkers.
In addition, cell-free DNA also aligns with the potential as it can be easily collected from blood samples and used in the context of non-invasive prenatal testing, screening for cancer, and other applications.
Plasma samples are also becoming a widely popular sample type to perform the SNP genotyping, as they can be easily obtained through the collection of the blood by the minimally invasive method and offer a rich source of genetic material.
Apart from these, whole blood is another commonly used sample type, although it is more difficult to analyze due to the need to extract the components from all the other blood components.
In conclusion, the Sample Type segment of the Global SNP Genotyping and Analysis Market is destined to expand most rapidly in the forthcoming years, due to the increasing adoption of the non-invasive liquid biopsy techniques, as well as the increased demand for personalized medicines.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
SNP Genotyping and Analysis Market Technology Insights
The Global SNP Genotyping and Analysis Market is segmented by Technology into Sanger Sequencing, Next-Generation Sequencing (NGS), Microarray-Based Genotyping, PCR-Based Genotyping, and Whole Genome Sequencing (WGS).
In 2023, NGS held the largest market share of 45.1%, and it is expected to continue to dominate the market throughout the forecast period.
The growth of the NGS segment can be attributed to its advantages over traditional Sanger sequencing, such as higher throughput, lower cost, and the ability to sequence larger genomes.
The Sanger Sequencing segment is expected to witness a steady growth rate during the forecast period due to its accuracy and reliability.
Microarray-Based Genotyping and PCR-Based Genotyping are expected to experience moderate growth rates, while Whole Genome Sequencing is expected to gain significant traction in the coming years due to its ability to provide a comprehensive view of an individual's genome.
SNP Genotyping and Analysis Market Application Insights
Disease Diagnostics is a major application segment in the Global SNP Genotyping and Analysis Market, accounting for a significant share of the market revenue. It is driven by the increasing demand for personalized medicine and the growing prevalence of genetic disorders.
Pharmacogenomics is another key segment, supported by the growing adoption of personalized medicine and the need for optimizing drug therapies based on individual genetic profiles.
Precision Medicine is also gaining traction, as it enables tailored medical treatments and therapies based on genetic information.
Forensic Science is another important segment, driven by the need for accurate identification and analysis of DNA samples.
Agriculture and Livestock is a growing segment, as SNP genotyping is used to improve crop yields and livestock breeding.
SNP Genotyping and Analysis Market End User Insights
The end user segment of the Global SNP Genotyping and Analysis Market is diverse, comprising various stakeholders involved in the field of genomics and genetic research.
Hospitals and clinics represent a significant segment, utilizing SNP Genotyping and Analysis for disease diagnostics, personalized medicine, and patient stratification. In 2023, this segment accounted for approximately 28.5% of the market revenue.
Research laboratories, including academic institutions and independent research organizations, are also key end users, driving market growth through advancements in genetic technologies and the development of novel applications.
Pharmaceutical and biotechnological companies leverage SNP Genotyping and Analysis for drug discovery, biomarker identification, and personalized drug development. Diagnostic laboratories provide specialized genetic testing services, contributing to the market's growth.
Academic and government institutions play a crucial role in research and development, advancing the understanding of genetic variations and their impact on health and disease.
The overall market segmentation provides insights into the diverse end-user landscape and their specific requirements, shaping the development and commercialization strategies for SNP Genotyping and Analysis solutions.
SNP Genotyping and Analysis Market Methodology Insights
Population-based studies, association studies, genome-wide association studies (GWAS), candidate gene studies, and family-based studies are some of the most common methodologies used in SNP Genotyping and Analysis.
The increasing prevalence of chronic diseases, rising demand for personalized medicine, and technological advancements in genetic sequencing are major factors driving the growth of the market.
Population-based studies involve collecting data from a large population to identify genetic variants associated with specific diseases.
Association studies examine the relationship between genetic variants and disease risk, while GWAS analyzes the entire genome to identify genetic variations associated with complex traits.
Candidate gene studies focus on specific genes that are known to be associated with certain diseases, and family-based studies investigate the inheritance patterns of genetic variants within families.
These methodologies contribute to our understanding of the genetic basis of diseases and aid in the development of targeted therapies and preventive measures.
SNP Genotyping and Analysis Market Regional Insights
The Global SNP Genotyping and Analysis Market is segmented into North America, Europe, APAC, South America, and MEA. Among these regions, North America accounted for the largest share of the market in 2023 and is expected to continue dominating the market throughout the forecast period.
The growth of the North American market is attributed to the increasing prevalence of chronic diseases, rising healthcare expenditure, and the presence of major market players in the region.
Europe is the second-largest market for SNP Genotyping and Analysis and is expected to witness significant growth over the forecast period due to the increasing adoption of personalized medicine and the growing demand for genetic testing services.
The APAC market is expected to be the fastest-growing market for SNP Genotyping and Analysis, driven by the rising healthcare expenditure, increasing awareness about genetic testing, and the growing number of healthcare facilities in the region.
South America and MEA are expected to witness moderate growth over the forecast period due to the limited access to healthcare facilities and the low awareness about genetic testing in these regions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
SNP Genotyping and Analysis Market Key Players and Competitive Insights:
Major players in the SNP Genotyping and Analysis Market are constantly striving to gain a competitive edge by developing and launching innovative products and technologies.
Leading SNP Genotyping and Analysis Market players are investing heavily in research and development to stay ahead of the competition.
The SNP Genotyping and Analysis Market development is being driven by factors such as increasing demand for personalized medicine and the growing adoption of next-generation sequencing technologies.
The SNP Genotyping and Analysis Market Competitive Landscape is expected to remain highly competitive in the coming years.
Illumina is a leading provider of SNP Genotyping and Analysis Market solutions. The company offers a wide range of products and services, including genotyping arrays, sequencing systems, and data analysis software.
Illumina's products are used by researchers around the world to study human health and disease. The company has a strong track record of innovation and has been a major player in the SNP Genotyping and Analysis Market for many years.
Thermo Fisher Scientific is another major player in the SNP Genotyping and Analysis Market. The company offers a wide range of products and services, including qPCR instruments, microarrays, and reagents.
Thermo Fisher Scientific's products are used by researchers in a variety of fields, including genetics, oncology, and infectious disease. The company has a strong global presence and is a trusted partner for many researchers around the world.
Key Companies in the SNP Genotyping and Analysis Market Include:
- LGC
- Invitae
- Illumina
- PerkinElmer
- QIAGEN
- BioRad Laboratories
- Counsyl
- Agilent Technologies
- Thermo Fisher Scientific
- Roche Diagnostics
- Eurofins Scientific
- Myriad Genetics
SNP Genotyping and Analysis Market Developments
Key factors driving market growth include the increasing prevalence of chronic diseases, technological advancements in genotyping and sequencing technologies, and the growing adoption of personalized medicine.
Recent developments in the market include the launch of new products such as Thermo Fisher Scientific's Ion Torrent Genexus System and Illumina's NextSeq 2000 Sequencing System.
Additionally, collaborations between industry players and research institutions are expected to further drive market growth.
SNP Genotyping and Analysis Market Segmentation
SNP Genotyping and Analysis Market Sample Type Outlook
- Genomic DNA
- RNA
- Cell-free DNA (cfDNA)
- Plasma Samples
- Whole Blood
SNP Genotyping and Analysis Market Technology Outlook
- Sanger Sequencing
- Next-Generation Sequencing (NGS)
- Microarray-Based Genotyping
- PCR-Based Genotyping
- Whole Genome Sequencing (WGS)
SNP Genotyping and Analysis Market Application Outlook
- Disease Diagnostics
- Pharmacogenomics
- Precision Medicine
- Forensic Science
- Agriculture and Livestock
SNP Genotyping and Analysis Market End User Outlook
- Hospitals and Clinics
- Research Laboratories
- Pharmaceutical and Biotechnological Companies
- Diagnostic Laboratories
- Academic and Government Institutions
SNP Genotyping and Analysis Market Methodology Outlook
- Population-Based Studies
- Association Studies
- Genome-Wide Association Studies (GWAS)
- Candidate Gene Studies
- Family-Based Studies
SNP Genotyping and Analysis Market Regional Outlook
- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2023 |
24.30 (USD Billion) |
| Market Size 2024 |
28.66 (USD Billion) |
| Market Size 2032 |
115.92 (USD Billion) |
| Compound Annual Growth Rate (CAGR) |
19.09% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
LGC, Invitae, Illumina, PerkinElmer, QIAGEN, BioRad Laboratories, Counsyl, Agilent Technologies, Thermo Fisher Scientific, Roche Diagnostics, Eurofins Scientific, Myriad Genetics |
| Segments Covered |
Sample Type, Technology, Application, End User, Methodology, Regional |
| Key Market Opportunities |
1 Personalized medicine SNP Genotyping and Analysis can help identify individuals at risk for specific diseases and tailor treatments accordingly. 2 Precision agriculture SNP genotyping can help optimize crop production by identifying genetic traits that influence yield and resistance to pests and diseases. 3 Forensic science SNP genotyping is used in DNA fingerprinting for identification and paternity testing. 4 Population genetics SNP genotyping can help trace human migrations and evolution. 5 Drug discovery SNP genotyping can identify genetic variants that influence drug response and side effects. |
| Key Market Dynamics |
Rising demand for personalized medicine Technological advancements in genotyping and sequencing The growing burden of genetic diseases Increasing adoption of AI and ML in data analysis Expansion of genomic databases |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Global SNP Genotyping and Analysis Market is expected to reach a valuation of USD 28.66 billion in 2024 and USD 115.92 billion by 2032, exhibiting a CAGR of 19.09% during the forecast period
North America is expected to dominate the Global SNP Genotyping and Analysis Market throughout the forecast period. The region's dominance can be attributed to the presence of many key players, advanced healthcare infrastructure, and increasing adoption of personalized medicine.
SNP Genotyping and Analysis finds applications in various fields, including Genetic research, Personalized medicine, Disease diagnosis and prognosis, and Drug discovery and development.
Key competitors in the Global SNP Genotyping and Analysis Market include Thermo Fisher Scientific- Illumina- Agilent Technologies- QIAGEN- Bio-Rad Laboratories.
Major factors driving the growth of the Global SNP Genotyping and Analysis Market include increasing prevalence of chronic diseases, Growing adoption of personalized medicine, Technological advancements in genotyping and analysis techniques, and Rising demand for genetic testing for disease risk assessment and prevention.
The Global SNP Genotyping and Analysis Market is anticipated to register a CAGR of 19.09% from 2024 to 2032.
Challenges faced by the Global SNP Genotyping and Analysis Market include the High cost of genotyping and analysis, Data privacy and ethical concerns, and Lack of skilled professionals.
Opportunities for growth in the Global SNP Genotyping and Analysis Market include Expansion into emerging markets, Development of new and innovative technologies, and Growing demand for personalized medicine.
Key trends in the Global SNP Genotyping and Analysis Market include Miniaturization and automation of genotyping and analysis technologies, Increasing use of artificial intelligence and machine learning, and Growing adoption of cloud-based data storage and analysis solutions.
The COVID-19 pandemic had a significant impact on the Global SNP Genotyping and Analysis Market. The pandemic led to disruptions in supply chains, delayed clinical trials, and reduced demand for genetic testing services. However, the market is expected to rebound in the post-pandemic period, driven by the increasing demand for genetic testing for disease risk assessment and prevention.
